GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allmed Solutions Ltd (XTAE:ALMD) » Definitions » ROE % Adjusted to Book Value

Allmed Solutions (XTAE:ALMD) ROE % Adjusted to Book Value : -16.84% (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Allmed Solutions ROE % Adjusted to Book Value?

Allmed Solutions's ROE % for the quarter that ended in Jun. 2024 was -13.81%. Allmed Solutions's PB Ratio for the quarter that ended in Jun. 2024 was 0.82. Allmed Solutions's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -16.84%.


Allmed Solutions ROE % Adjusted to Book Value Historical Data

The historical data trend for Allmed Solutions's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allmed Solutions ROE % Adjusted to Book Value Chart

Allmed Solutions Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.73 -18.51 8.07 -45.81 3.57

Allmed Solutions Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.88 -70.42 80.82 -45.89 -16.84

Competitive Comparison of Allmed Solutions's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Allmed Solutions's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allmed Solutions's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allmed Solutions's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Allmed Solutions's ROE % Adjusted to Book Value falls into.



Allmed Solutions ROE % Adjusted to Book Value Calculation

Allmed Solutions's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=2.71% / 0.76
=3.57%

Allmed Solutions's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-13.81% / 0.82
=-16.84%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allmed Solutions ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Allmed Solutions's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Allmed Solutions Business Description

Traded in Other Exchanges
N/A
Address
2 Ha-Eshel Street, P.O.BOX 3081, Caesarea Industrial Park, Caesarea, ISR, 3079501
Allmed Solutions Ltd is a medical device company. It researches, develops, manufactures and markets peripheral stents and medical devices. It has developed a proprietary stent technology platform to expedite the development of site-specific stents. It also develops medical devices focused on minimal invasive therapy for the treatment of type 2 diabetes.

Allmed Solutions Headlines

No Headlines